This inventor holds 1 USPTO granted patent. Top assignee: Roche Diagnostics Gmbh. Active years: 2002.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2002
Title: Hendrik Von Burën: Innovator in Pharmaceutical Technology
Introduction
Hendrik Von Burën is a notable inventor based in Nussloch, Germany. He has made significant contributions to the field of pharmaceutical technology, particularly in the development of innovative drug delivery systems. His work focuses on enhancing the effectiveness of medications through advanced formulation techniques.
Latest Patents
Hendrik Von Burën holds a patent for "Rapidly disintegrating coated pellets with delayed release." This invention pertains to pharmaceutical forms of administration that are designed as pellets containing a retarding agent. The unique aspect of this invention is that the release rate of the active substance remains substantially identical to corresponding pellets that do not contain a retarding agent. Notably, these rapidly disintegrating pellets achieve a release rate of at least about 90% within a time period of 30 minutes. Additionally, the patent includes processes for the production of these innovative pellets.
Career Highlights
Hendrik is associated with Roche Diagnostics GmbH, a leading company in the field of diagnostics and pharmaceuticals. His work at Roche has allowed him to contribute to advancements in drug formulation and delivery systems, enhancing patient care and treatment outcomes.
Collaborations
Hendrik has collaborated with esteemed colleagues such as Rolf-Dieter Gabel and Michaela Opitz. These collaborations have fostered a productive environment for innovation and have led to the development of cutting-edge pharmaceutical technologies.
Conclusion
Hendrik Von Burën's contributions to pharmaceutical technology through his innovative patent and work at Roche Diagnostics GmbH highlight his role as a key figure in advancing drug delivery systems. His dedication to improving medication effectiveness continues to impact the field positively.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
